Jan 2026· Human Mutation· Vol 2026· 0 citations· 35 references
Medicine
TL;DR
It is demonstrated that some cryptic donor–acceptor motif pairings are likely incompatible with splicing, which may inform future improvements in in silico splice site prediction tools.
Abstract
Variants affecting minor (U12‐type) intron splice sites are underreported, and their consequences are poorly understood, which makes predicting their pathogenicity challenging. We investigated the impact on splicing of an SCN5A minor intron donor variant in an individual with cardiac arrhythmias using patient‐specific induced pluripotent stem cell cardiomyocytes (iPSC‐CMs). Genetic testing in the proband identified an SCN5A c.392+3A>G variant of uncertain significance in a minor intron donor splice site, which segregated in affected family members with cardiac phenotypes, including Brugada syndrome. Transcriptome sequencing of proband‐specific iPSC‐CMs, treated with and without inhibition of nonsense‐mediated decay, revealed aberrant SCN5A splicing. Four variant‐associated isoforms were absent from control iPSC‐CMs and control myectomy samples, and one skipped Exon 3 with a 96 bp extension of Exon 4. All alternatively spliced SCN5A transcripts were T/A cloned and confirmed by Sanger sequencing. These alternatively spliced transcripts used novel combinations of cryptic minor and major splice sites and introduced premature termination codons or an in‐frame deletion, supporting reclassification of the variant as likely pathogenic. A genome‐wide analysis of SpliceAI scores across minor intron splice sites retrieved from the Minor Intron Database revealed clear patterns of variants with high predicted splicing impact. This analysis also highlighted distinct splice site sequence motifs between minor and major splice sites that are not currently considered in ACMG/AMP variant interpretation guidelines. We further demonstrate that some cryptic donor–acceptor motif pairings are likely incompatible with splicing, which may inform future improvements in in silico splice site prediction tools. Integrating functional RNA sequencing with SpliceAI‐based predictions at minor introns offers a pathway towards refining variant interpretation frameworks in clinical genomics.
The present case contributes a homozygous splice‐site variant with experimentally confirmed aberrant splicing and an in‐frame protein alteration in titin, providing additional case‐level and functional evidence for a possible role of specific TTN splicing defects in HCM.
Xiao-Yun Sun, Dan-Dan Wang, Shu-Juan Wang et al.· Human Mutation· 0 citations
BACKGROUND: Disruption of MYBPC3 precursor mRNA splicing is a frequent genetic cause of hypertrophic cardiomyopathy (HCM). Most often, it reflects changes at canonical sites or the creation of novel splice sites. Prediction tools usually prioritize splice variants with lower efficiency when they are distant from canoni...
M. Gallego-Delgado, S. L. Lorenzo Hernández, Soledad García Hernández et al.· Circulation· 0 citations
The first deep intronic EIF2AK3 variant causing Wolcott-Rallison syndrome is reported, highlighting the need to consider systematic intronic analysis in unresolved cases.
Alaa Al Assi, G. Bonfield, J. Russ-Silsby et al.· Diabetic Medicine· 0 citations
This review synthesizes the molecular basis of splice-altering variants, current standards for their nomenclature and computational prediction, the practical strengths and limitations of RNA-level validation, and their contribution to epilepsy, hereditary neuropathy, ataxia, dystonia, mitochondrial disease, neuromuscul...
Nishanth Gowda, S. Harish· Neurogenetics· 0 citations
This gene-agnostic framework establishes a systematic strategy for identifying intronic mutational hotspots and matching patients to scalable, mutation-agnostic ASO-based precision therapies.
H. Saei, B. Ardin, N. Kaiser et al.· medRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.